Syndax Pharmaceuticals, Inc.
SNDX
$16.24
$0.402.53%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.32% | 9.90% | -11.94% | -23.60% | 5.99% |
| Total Depreciation and Amortization | -- | -- | -100.00% | -33.33% | 0.00% |
| Total Amortization of Deferred Charges | -50.89% | 273.33% | -- | -- | -- |
| Total Other Non-Cash Items | 53.50% | -26.80% | 4.30% | 41.33% | 21.93% |
| Change in Net Operating Assets | -53.48% | -164.11% | 115.23% | 225.38% | 38.85% |
| Cash from Operations | 7.74% | -65.82% | 7.92% | 13.01% | 14.25% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -55.51% | 135.00% | -409.71% | 40.64% | 162.12% |
| Cash from Investing | -55.51% | 135.00% | -409.71% | 40.64% | 162.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -40.75% | -75.35% | 21.79% | 358.28% | -68.82% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -40.75% | -99.73% | 11,114.49% | 358.28% | -68.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -50,296.67% | -100.43% | -23.74% | 399.63% | 94.90% |